Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Adaptimmune
Adaptimmune
These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences
Adaptimmune and GSK Expand Strategic Immunotherapy Collaboration
Yahoo
Tue, 02/2/16 - 01:26 pm
Adaptimmune
GSK
immunotherapy
9 Biotech Picks for 2016
Barron's
Sat, 01/2/16 - 10:19 am
biotech
Adaptimmune
Dermira
FibroGen
Incyte
Intra-Cellular Therapies
Seres Therapeutics
Ophthotech
Neurocrine Biosciences
Paratek
Adaptimmune pockets GSK payouts after tripling size of TCR trial
Fierce Biotech
Thu, 09/3/15 - 08:42 am
Adaptimmune
GSK
synovial sarcoma
NY-ESO-1
3 Biotech Stocks Wall Street Hates
Motley Fool
Sat, 08/15/15 - 11:03 am
Northwest Biotherapeutics
Adaptimmune
MannKind
Drug developer Adaptimmune skids after IPO raises $191M
Yahoo/AP
Wed, 05/6/15 - 02:12 pm
Adaptimmune
IPOs
Another IPO Filed In Hot Cancer Immunotherapy Field
Investors.com
Wed, 04/8/15 - 10:13 am
IPOs
cancer immunotherapy
Adaptimmune
Adaptimmune's novel cancer treatment posts promising early results
Fierce Biotech
Fri, 10/17/14 - 09:26 am
Adaptimmune
GSK
cancer immunotherapy
Adaptimmune raises $104 mln to develop immune-system cancer drugs
Yahoo/Reuters
Wed, 09/24/14 - 09:39 pm
Adaptimmune
immuno-oncology
GSK in $350 million deal to develop cancer drugs with UK biotech firm
Yahoo/Reuters
Mon, 06/2/14 - 10:02 am
GSK
R&D
cancer
UK
Adaptimmune
Pages
« first
‹ previous
1
2